Toxic injury of the CNS

Published on 19/03/2015 by admin

Filed under Pathology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2336 times

25

Toxic injury of the CNS

Toxin-induced injuries of the central nervous system (CNS) are an increasing clinical problem. Contributing factors include:

Exogenous toxins include gases (e.g. carbon monoxide), metals (such as mercury), liquids (ethanol) and many solids. Exogenous toxins may be natural or synthetic (also called neurotoxicants), many drugs falling into the latter category. Toxins may also be produced within the body: endogenous neurotoxins. A prime example is the excitatory neurotransmitter glutamate, toxic to neurons if present in excess (a phenomenon known as excitotoxicity). Other endogenous neurotoxins include free radicals, trace elements, lipid peroxidation products, catechol derivatives and advanced glycation endproducts.

After exposure to a neurotoxin, symptoms and signs may appear immediately or be delayed. The manifestations are often non-specific and may include headache, cognitive and behavioral changes, visual disturbances, sexual dysfunction, seizures, narcosis, and depression of consciousness.

In acute toxic encephalopathies, the most consistent and striking finding is brain edema. The brain is heavy and swollen and in severe cases, transtentorial and cerebellar tonsillar herniation may occur. Cerebral edema secondary to vascular damage, as in lead encephalopathy, or direct damage to CNS myelin, as in triethyltin encephalopathy, is largely confined to the white matter. In contrast, cytotoxic edema, as in thallium intoxication, typically affects both gray and white matter and may impart a ‘moth-eaten’ macroscopic appearance to the cortical ribbon. Histology confirms the edema, often associated with myelin pallor and reactive gliosis.

This chapter covers toxins that are known to produce lesions of the CNS. Some of them also cause peripheral neuropathy, but this will be mentioned only briefly (Tables 25.125.3).

METALS

ALUMINUM (ALUMINIUM)

Aluminum toxicity is most common in patients undergoing chronic hemodialysis and is due to high concentrations of aluminum in water used for the dialysis. It manifests clinically as dialysis encephalopathy syndrome, which is characterized by a combined dysarthria and apraxia of speech, myoclonus, gait disturbance, focal seizures, and dementia.

ARSENIC

MACROSCOPIC AND MICROSCOPIC APPEARANCES

The peripheral neuropathy caused by chronic trivalent arsenical intoxication may be associated with chromatolysis and loss of anterior horn cells. In patients with acute hemorrhagic leukoencephalopathy complicating organic pentavalent arsenical administration, the brain is swollen and contains numerous small and occasional larger foci of hemorrhage (Fig. 25.1). Histology reveals fibrinoid necrosis of many parenchymal blood vessels and hemorrhage into the surrounding tissue (Fig. 25.1). Some of the blood vessels are surrounded by a fibrin exudate containing a mixed inflammatory infiltrate. The findings are described in more detail in Chapter 20.

BISMUTH

LEAD

Lead has no known essential cellular function. It is a potent neurotoxicant, especially during nervous system development. At a molecular level, lead can substitute for calcium and thereby interferes with many metabolic processes.

MANGANESE

Clinical manifestations include extrapyramidal movement disorders that may resemble Parkinson’s disease, transient psychiatric disturbances, and intellectual impairment.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

In contrast to idiopathic Parkinson’s disease (see Chapter 28), the substantia nigra is preserved, but there is gliosis and a loss of neurons from the pallidum and subthalamic nucleus and, to a lesser extent, from the caudate and putamen.

MERCURY

MICROSCOPIC APPEARANCES

There is preferential loss of small neurons, particularly from the granule cell layer of the cerebellum and the primary visual, auditory, and somatosensory regions of the cerebral cortex, in which small neurons predominate. In severe cases, particularly in children, neuronal loss is more extensive and there is spongiform cortical degeneration. Other features include an associated gliosis and, in acute lesions, infiltration by macrophages. Degeneration of dorsal root ganglion cells results in some loss of nerve fibers from the posterior columns of the spinal cord. Sprouting of Purkinje cell dendrites is a prominent feature in long-term survivors, in whom granular deposits of mercury are demonstrable in astrocytes, microglia, and neurons (Fig. 25.2).

Fetal intoxication can cause neuronal heterotopia and cortical dysplasia in addition to degenerative lesions. Extensive architectural disruption of neuronal elements can be observed within the cerebellum.

TIN

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Triethyltin causes striking white matter edema in brain and spinal cord (Fig. 25.4) due to the accumulation of fluid in vacuoles within the myelin sheaths (Fig. 25.4). The vacuoles are formed by separation of myelin along intraperiod lines (Fig. 25.4). Trimethyltin does not cause intramyelinic edema, but is toxic to neurons in the hippocampus, basal ganglia, entorhinal cortex, and amygdala. It elicits specific apoptotic destruction of pyramidal neurons in the CA3 region of the hippocampus and in other limbic structures.

OTHER INDUSTRIAL CHEMICALS

ACRYLAMIDE

Prolonged low-level exposure causes peripheral neuropathy. Heavier exposure can cause tremor, ataxia, dysarthria, and mental disturbances.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

The brain and spinal cord appear macroscopically normal. Histology reveals swelling and degeneration of the distal part of longer axons in peripheral nerves and the posterior spinal, spinocerebellar, and corticospinal tracts. The swellings contain accumulations of neurofilaments.

CARBON DISULFIDE

MACROSCOPIC AND MICROSCOPIC APPEARANCES

The brain and spinal cord appear macroscopically normal, and histologic changes are sparsely documented. In the peripheral nervous system, carbon disulfide intoxication results in axonal swellings (Fig. 25.5), which contain abnormal accumulations of neurofilaments, and distal nerve fiber degeneration. Described CNS abnormalities include distal axonal spinocerebellar degeneration and increased cerebral atherosclerosis. Spinal long tracts contain neurofilamentous axonal swellings (Fig. 25.5). The distal axonopathy is probably secondary to progressive cross-linking and accumulation of neurofilaments during their anterograde transport in long axons.

CARBON TETRACHLORIDE

ETHYLENE GLYCOL

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Acute intoxication produces meningeal congestion and cerebral edema, and, occasionally, petechial hemorrhages. Microscopically, birefringent calcium oxalate deposits can usually be demonstrated by polarized light microscopy (Fig. 25.6) in and around vessels in the meninges, brain parenchyma, and choroid plexus. Neurons may show hypoxic change and there is often white matter edema. Scanty perivascular acute inflammatory infiltrates may be seen, but these are not consistently related to the calcium oxalate deposits and may be a reaction to hypoxic brain injury.

HEXACARBON SOLVENTS (N-HEXANE AND METHYL N-BUTYL KETONE)

MACROSCOPIC AND MICROSCOPIC APPEARANCES

The brain and spinal cord appear macroscopically normal. Histologic changes in the human CNS are sparsely documented, but there are many experimental studies demonstrating the formation of neurofilamentous axonal swellings (Fig. 25.7) and distal degeneration of nerve fibers in long ascending (spinocerebellar and posterior column) and descending (corticospinal) spinal tracts, as occur in the peripheral nerves. As in carbon disulfide intoxication, the changes are probably due to progressive cross-linking and accumulation of neurofilaments during their anterograde transport.

METHANOL

MACROSCOPIC AND MICROSCOPIC APPEARANCES

In acute methanol intoxication the brain is usually edematous and shows features of global hypoxic injury (see Chapter 8). There may be scattered petechial hemorrhages and larger, symmetric foci of hemorrhagic infarction in the putamen. In severe cases, hemorrhagic necrosis of the putamen is accompanied by more widespread hypoxic damage to the cerebral cortex and extensive white matter necrosis (Figs 25.825.10). Survivors of the acute toxicity may show putaminal cavitation, with accumulation of macrophages and reactive astrocytosis (Fig. 25.11). Degeneration of retinal ganglion cells results in optic nerve atrophy and gliosis.

ORGANOPHOSPHATES

TOLUENE

TOXIC OIL SYNDROME AND EOSINOPHILIA–MYALGIA SYNDROME

GASES

CARBON MONOXIDE

MACROSCOPIC APPEARANCES

During the first few hours, the brain is swollen, congested, and cherry-red in color, though this is less striking after prolonged formalin fixation. After 24–48 hours of survival, scattered petechial hemorrhages may be seen in the white matter and larger hemorrhages in the pallidum (Fig. 25.12). These usually involve the dorsal part of the inner segment of the pallidum, but may extend laterally into the outer segment or dorsomedially into the internal capsule. The pallidal lesions are often asymmetric (Fig. 25.12) and may be unilateral or absent. In some cases there are hemorrhages in the hippocampus and cerebral cortex. Following survival of several days or weeks, the lesions in the pallidum appear necrotic or cavitated (Fig. 25.12). Discrete or confluent foci of necrosis may also be evident in the white matter (Fig. 25.12). These tend to spare the arcuate fibers.

Although pallidal necrosis is typical of delayed death from carbon monoxide poisoning, it is not unique to this condition and can occur in other hypoxic states, methanol toxicity (see above), or cyanide toxicity (see below).

MICROSCOPIC APPEARANCES

In the acute stage there may be foci of necrosis and/or perivascular hemorrhage in the affected parts of the gray and white matter. Within days, these foci accumulate numerous lipid- or hemosiderin-laden macrophages. Lesions in longer-term survivors are cavitated (Fig. 25.13) or rarefied and gliotic. Typical changes of global brain hypoxia–ischemia of varying severity (see Chapter 8) are usually seen. The white matter lesions may be small and discrete, extensive, or even confluent. In some cases there is a loss of myelin, but relative preservation of axons in the deep white matter. This pattern tends to be associated with a delayed clinical deterioration. Arcuate fibers are usually spared (Fig. 25.14).

CYANIDE

MACROSCOPIC APPEARANCES

After acute intoxication, the brain usually appears normal, but if death is delayed by a few hours, there may be edema and small subarachnoid and petechial parenchymal hemorrhages. Necrotic foci have been noted in the white matter and pallida in the rare cases that survive days or weeks. These lesions are similar to those associated with carbon monoxide poisoning (see above).

NITROUS OXIDE

ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL, AND ANTIPROTOZOAL DRUGS

CLIOQUINOL

HEXACHLOROPHENE (USA)/HEXACHLOROPHANE (UK)

Hexachlorophene is a phenolic antiseptic widely used to sterilize the skin pre-operatively and to prevent neonatal sepsis, and is present in some cosmetics. It can, however, be absorbed in toxic quantities through the mucous membranes and skin, particularly of premature infants and burns patients. Excessive absorption may cause irritability, nausea and vomiting, visual disturbances, drowsiness and convulsions, and, in severe poisoning, coma and death.

MISCELLANEOUS ANTIBIOTICS

Encephalopathy is a rare complication of therapy with several antibiotics and is usually reversible. Very rarely, neuropathologic changes have been reported.

image Chloramphenicol may cause optic atrophy and peripheral neuropathy after prolonged high-dose administration.

image Cycloserine, ethionamide, and pyrazinamide may cause a pellagra-like syndrome similar to that associated with isoniazid toxicity (see below).

image Gentamicin is a rare cause of encephalopathy. Foci of white matter necrosis and calcification have been observed in the midbrain and pons after intrathecal administration. The aminoglycosides, including gentamicin, are all ototoxic.

image Overdosage is a particular risk in slow acetylators of the antituberculous drug isoniazid (isonicotinic acid hydrazide, INH), and especially in patients with impaired renal function. INH chelates pyridoxal phosphate and the resulting inhibition of pyridoxal phosphokinase and impaired conversion of tryptophan to niacin produces an acute pellagra-like syndrome, which responds to pyridoxine (vitamin B6) administration. The occurrence of seizures is thought to be due to inhibition of the synthesis of the inhibitory neurotransmitter γ-aminobutyric acid. Visual disturbances and optic atrophy have been reported.

image Ethambutol can cause visual disturbances and optic atrophy.

image Metronidazole can cause a reversible encephalopathy in high doses. The most common clinical manifestations are dysarthria, gait disturbance, weakness of the extremities, and confusion. On MR imaging, high T2 signal is often seen in the dentate nuclei in the cerebellum but may also involve the tectum, red nucleus, periaqueductal gray matter, and dorsal pons. The abnormalities are reversible on discontinuation of the drug.

image Nimorazole, an anti-protozoal drug that is also used to sensitize hypoxic tumor cells to radiotherapy, has been reported to cause foci of cerebral and cerebellar white matter necrosis, with a predilection for long fiber tracts, and lesions similar to Leigh’s disease in the brain stem and cerebellar dentate nuclei. Interference with mitochondrial function, with resulting energy deprivation, was the postulated mechanism.

image Penicillins can cause seizures, partly because the β-lactam ring binds to γ-aminobutyric acid receptors. Hydrophobic penicillins such as cloxacillin and dicloxacillin are most likely to be neurotoxic.

image Sulfonamides (USA)/sulphonamides (UK) very rarely cause acute psychosis, meningism, and myelitic symptoms. Neuropathologic examination of fatal cases has shown vascular endothelial swelling and necrosis, and scattered foci of necrosis with or without hemorrhage in the gray and white matter.

ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE AGENTS

CALCINEURIN INHIBITORS: CYCLOSPORINE A (CSA) AND TACROLIMUS (FK506)

Cyclosporine, a neutral lipophilic cyclic undecapeptide isolated from the fungus Hypocladium inflatum gams binds with high affinity to cyclophilins, especially to cyclophilin A in T cells. The cyclosporine– cyclophilin complex associates with and inactivates calcineurin, thereby preventing the dephosphorylation and activation of a series of cytokine gene transcription factors. Tacrolimus, a macrolide lactone isolated from the fungus Streptomyces tsukubaensis, binds to immunophilin–FK binding protein-12 in T cells. The resulting complex inhibits calcineurin activity. Cyclosporine and tacrolimus are widely used as immunosuppressants to prevent transplant rejection, and for the treatment of autoimmune and other inflammatory diseases. Both drugs can cause neurotoxicity.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

There are few reports on the neuropathologic findings in human toxicity. The parieto-occipital white matter may be edematous. Electron microscopy in one case showed detachment of astrocytic foot-processes from blood vessels in the white matter. Vasculitis has also been reported. Rarely, there is also extensive axonal damage and degeneration, with loss of myelin and infiltration by macrophages (Fig. 25.16).

METHOTREXATE

Methotrexate is a folic acid antagonist used to treat leukemias and lymphomas as well as some solid tumors. Neurotoxicity is associated with high dosage or intrathecal administration, particularly in conjunction with craniospinal X-irradiation.

MICROSCOPIC APPEARANCES

There is a loss of myelin and swelling and fragmentation of axons within foci of coagulative necrosis in the white matter (Fig. 25.17). Multifocal axonal injury with accumulation of β-amyloid precursor protein may be demonstrable immunohistochemically. Lipid-laden macrophages are plentiful in the early stages. The axonal swellings and other cellular debris tend to calcify. In longer-term survivors the white matter may be reduced to an attenuated layer of gliotic, focally calcified tissue. Vascular abnormalities are present in some cases and include perivascular fibrin exudates, fibrinoid vascular necrosis, and a non-inflammatory mineralizing angiopathy, which is most severe in the lenticular nuclei. Intra-arterial methotrexate administration has caused multiple hemorrhagic infarcts due to fibrinoid necrosis and thrombosis of small blood vessels.

CISPLATIN

Like carboplatin, which is much less neurotoxic, cisplatin is a platinum (II) complex with two ammonia groups in the cis position. It is used for treating ovarian carcinomas, head and neck cancers, malignant gliomas, and small-cell carcinomas of the lung. Cisplatin therapy is frequently complicated by a distal sensory neuropathy affecting both peripheral and central (posterior column) projections of the dorsal root ganglia. Intra-arterial administration in the treatment of head and neck cancers can produce a neuropathy involving the cranial nerves. Cisplatin can also cause an acute reversible encephalopathy and, very rarely, necrotizing leukoencephalopathy.

NUCLEOSIDE ANALOGS

The pyrimidine analog cytosine arabinoside (ara-C) is used to treat leukemia. Neurotoxicity is rare. The risk increases with age and is greater after intrathecal than after systemic administration. 5-fluorouracil and its derivatives tegafur and carmofur are used in the treatment of various gastrointestinal, breast, and ovarian carcinomas, and can cause either focal neurologic deficits or an encephalopathy. The purine analog fludarabine is used mainly for the treatment of leukemias. Fludarabine can cause an acute or subacute encephalopathy; the risk is greatest amongst patients receiving high doses of this drug but neurotoxicity has occasionally occurred in association with relatively low dose treatment.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Reported findings in cases of cytosine arabinoside toxicity include cerebellar cortical degeneration and karyorrhexis of brain stem tegmental and spinal motor neurons associated with perikaryal accumulation of masses of neurofilaments. White matter vacuolation and loss of nerve fibers have been noted in the spinal cord.

Experimentally, 5-fluorouracil and its derivatives cause intramyelinic edema and foci of gray matter softening and necrosis in the cerebellum and brain stem. Findings in human intoxication have included neuronal degeneration involving Purkinje cells and the dentate and inferior olivary nuclei, and an inflammatory cerebral demyelinating disease.

Autopsy examination of the brain in patients with fludarabine-associated neurotoxicity has shown a necrotizing leukoencephalopathy (Fig. 25.18) most severe in the occipital lobes, but also involving the medullary pyramids and posterior spinal columns. The subcortical white matter lesions may extend into the adjacent cerebral cortex.

MISCELLANEOUS THERAPEUTIC OR DIAGNOSTIC DRUGS

PHENYTOIN

MACROSCOPIC AND MICROSCOPIC APPEARANCES

There may be obvious atrophy of the cerebellar vermis and hemispheres (Fig. 25.19). Microscopic findings are relatively nonspecific, with severe loss of Purkinje, and usually, granule cells (Fig. 25.19). There is marked proliferation of Bergmann astrocytes, with associated isomorphic gliosis (Fig. 25.19). The cerebellar cortical degeneration is usually diffuse, but may be patchy.

STREET DRUGS

Psychiatric and neurologic abnormalities are the very common manifestations of drug toxicity, reflecting a broad spectrum of changes affecting the central nervous system. The most common of these are secondary to brain ischemia, resulting from cardiorespiratory depression or vascular occlusion. The neurochemical actions of some drugs can produce marked hyperthermia with consequent systemic and neurological injury. A wide range of abnormalities has been described in polydrug abusers, including neuronal loss, astrocytosis or in some cases depletion of GFAP-immunopositive astrocytes, axonal damage, microglial activation, and reactive and degenerative changes of the cerebral microvasculature.

COCAINE

Neurologic complications may result from intravenous or intramuscular injection, smoking, or snorting of cocaine. Alkaloidal forms (i.e. ‘crack’) are sometimes responsible. Neurologic manifestations of toxicity range from mydriasis with blurred vision, headache, vomiting, and vertigo, to stereotyped repetitive movements, dystonia, hyperreflexia, myoclonus, seizures, coma, and death. The presentation may resemble neuroleptic malignant syndrome. Migraine-like headaches with transient hemiparesis or focal or generalized seizures can occur without other signs of toxicity.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Neuropathologic complications include arterial infarcts, and subarachnoid or parenchymal hemorrhages (Fig. 25.20):

The spinal cord may be affected.

Rupture of saccular (berry) aneurysms (see Chapter 10) is a well-documented complication of cocaine abuse in young adults and is thought to be due to the transient, but occasionally marked, hypertension.

The vasoconstrictive action of chronic intranasal cocaine can cause local soft tissue and bony erosion. Rarely this results in CSF rhinorrhea and secondary bacterial or fungal infection.

HEROIN (DIAMORPHINE)

Heroin is usually injected intravenously or snorted. Neurologic manifestations of toxicity range from anorexia, nausea, and vomiting, to cardiorespiratory depression, coma, and death. Ischemic CNS complications include cerebral infarcts, ischemic myelopathy, and global hypoxic–ischemic brain injury (Fig. 25.21).

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Angiographic findings have been suggestive of a small vessel angiitis in some patients. However, the predominant findings have been watershed infarcts, laminar sclerosis, and bilateral infarcts of the globus pallidum, all presumably due to a combination of reduced cerebral perfusion and global hypoxia. The spinal cord may be affected. Refractile embolic particles of foreign material have been observed in the skin, and rarely in the spinal cord of heroin users, but not in the brain.

MPTP (1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE)

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Neuropathologic examination reveals nigrostriatal neuronal degeneration in a pattern closely resembling that of idiopathic Parkinson’s disease (see Chapter 29). Typical Lewy bodies are, however, not seen. In experimental studies:

ETHANOL (‘ALCOHOL’)

Ethanol affects the nervous system through a variety of direct and indirect mechanisms, the latter including metabolic disturbances produced by ethanol-induced organ (especially liver) damage and various nutritional deficiencies that tend to complicate chronic alcohol abuse. In addition, alcoholism predisposes to infections, is associated with an increased likelihood of sustaining traumatic injuries, and increases the risk of hemorrhagic strokes. Alcoholism and its associated nutritional deficiencies are important causes of peripheral neuropathy. Some of the direct and indirect toxic effects of ethanol on the CNS are discussed below, while Wernicke–Korsakoff syndrome and pellagra are discussed in the context of nutritional deficiencies (see Chapter 21). Central pontine myelinolysis is considered with other metabolic disorders in Chapter 22.

CEREBELLAR DEGENERATION

The clinical manifestations of cerebellar degeneration in alcoholics evolve over months or years and include truncal instability, a broad-based stance, and gait ataxia. Men are more often affected than women.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Neuropathologic examination reveals atrophy of the superior part of the vermis and adjacent regions of the cerebellar hemispheres, with atrophy of the folia and widening of the sulci (Fig. 25.22). In contrast to the pattern of degeneration resulting from hypoxia, the crests of the folia tend to be more severely affected than the depths of the sulci. There is a loss of Purkinje cells, a patchy loss of granule cells with resulting atrophy of the molecular layer, and proliferation of Bergmann glia (Fig. 25.22). Neuronal loss and gliosis are usually evident in the dorsal layer of the inferior olivary nuclei (Fig. 25.22). The vestibular, fastigial, globose, and emboliform nuclei may show mild degenerative changes.

MARCHIAFAVA–BIGNAMI DISEASE

Although originally reported to affect poorly nourished Italian males who had consumed large amounts of crude red wine over many years, this rare disorder has since been described in chronic alcoholics in other populations and even in malnourished non-alcoholics. The pathogenesis is unknown.

Marchiafava–Bignami disease is commonly associated with other manifestations of chronic alcohol abuse such as Wernicke’s encephalopathy, central pontine myelinolysis, and Morel’s laminar sclerosis.

MICROSCOPIC APPEARANCES

Histologically, the disorder is characterized by variable combinations of necrosis and demyelination. These most consistently involve the genu and body of the corpus callosum and spare a thin layer of myelinated fibers along the dorsal and ventral surfaces (Fig. 25.23). Other white matter structures may be involved, as noted above. Macrophages are abundant in the early stages, but lymphocytic inflammation is not a feature. Oligodendrocytes are markedly reduced in number, and astrocytes generally show only modest reactive changes. A striking feature is the proliferation and hyaline thickening of small blood vessels.

MOREL’S LAMINAR SCLEROSIS

This is characterized by a band of spongiosis and gliosis involving the third layer (and, in some cases, deeper layers also) of the frontal and temporal cortex (Fig. 25.24). It is usually associated with, and may be secondary to, the callosal lesions of Marchiafava–Bignami disease, but has also been reported as an isolated finding in chronic alcoholics.

BIOLOGIC TOXINS

CLOSTRIDIUM TETANI EXOTOXIN

Clostridium tetani is an anaerobic soil saprophyte that produces exotoxin in soil-contaminated wounds. The toxin gains access to the nervous system by retrograde axonal transport and once in the nervous system inhibits the inhibitory neurotransmitters γ-aminobutyric acid and glycine. The incubation period is usually 5–25 days, but may be shorter. Rare sources of infection are unclean needles used by drug addicts and dung applied to the stump of the umbilical cord. The clinical manifestations are muscle spasms and rigidity, often including trismus at an early stage (lock-jaw), low-grade pyrexia, sweating, and autonomic disturbances.

DOMOIC ACID

REFERENCES

General reading

Bolon, B., Garman, R., Jensen, K., Ad Hoc Working Group of the STP Scientific and Regulatory Policy Committee. A ‘best practices’ approach to neuropathologic assessment in developmental neurotoxicity testing – for today. Toxicol Pathol. 2006;34:296–313.

Calabrese, E.J. Astrocytes: adaptive responses to low doses of neurotoxins. Crit Rev Toxicol.. 2008;38:463–471.

Eicher, T., Avery, E. Toxic encephalopathies. Neurol Clin.. 2005;23:353–376.

Finkelstein, Y., Milatovic, D., Lazarovici, P., et al. Peaceful use of disastrous neurotoxicants. Neurotoxicology.. 2010;31:608–620.

Genuis, S.J. Toxic causes of mental illness are overlooked. Neurotoxicology.. 2008;29:1147–1149.

Guidotti, M., Chiveri, L., Mauri, M. Acute encephalopathies. Neurol Sci.. 2006;27:S55–S56.

Philbert, M.A., Billingsley, M.L., Reuhl, K.R. Mechanisms of injury in the central nervous system. Toxicol Pathol.. 2000;28:43–53.

Segura Aguilar, J., Kostrzewa, R.M. Neurotoxins and neurotoxic species implicated in neurodegeneration. Neurotox Res. 2004;6:615–630.

Wallace, D.R. Overview of molecular, cellular, and genetic neurotoxicology. Neurol Clin.. 2005;23:307–320.

Metals

Bondy, S.C. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology.. 2010;31:575–581.

Burton, N.C., Guilarte, T.R. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ Health Perspect.. 2009;117:325–332.

Ceccatelli, S., Daré, E., Moors, M. Methylmercury-induced neurotoxicity and apoptosis. Chem Biol Interact.. 2010;188:301–308.

Crossgrove, J., Zheng, W. Manganese toxicity upon overexposure. NMR Biomed.. 2004;17:544–553.

Dobson, A.W., Erikson, K.M., Aschner, M. Manganese neurotoxicity. Ann N Y Acad Sci.. 2004;1012:115–128.

Fitsanakis, V.A., Aschner, M. The importance of glutamate, glycine, and gamma-aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. Toxicol Appl Pharmacol.. 2005;204:343–354.

Jenkins, S.M., Barone, S. The neurotoxicant trimethyltin induces apoptosis via caspase activation, p38 protein kinase, and oxidative stress in PC12 cells. Toxicol Lett.. 2004;147:63–72.

Lidsky, T.I., Schneider, J.S. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain.. 2003;126:5–19.

Murata, K., Iwata, T., Dakeishi, M., et al. Lead toxicity: does the critical level of lead resulting in adverse effects differ between adults and children? J Occup Health.. 2009;51:1–12.

Sanders, T., Liu, Y., Buchner, V., et al. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health.. 2009;24:15–45.

White, L.D., Cory-Slechta, D.A., Gilbert, M.E., et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol.. 2007;225:1–27.

Wright, R.O., Baccarelli, A. Metals and neurotoxicology. J Nutr.. 2007;137:2809–2813.